Press Release | January 3, 2022
Smart Meter partners with AT&T IoT for better health outcomes
Get Closer To The Patient
With Data and Device Infrastructure for Remote Patient Monitoring and Chronic Care Management
1 
Get Closer To The Patient
With Data and Device Infrastructure for Remote Patient Monitoring and Chronic Care Management
1
REDUCE PATIENT CHURN – FREE PROGRAM AVAILABLE NOW!
Talk to your account representative today to learn more.
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter has propelled virtual care forward with our full suite of cellular-connected, FDA approved devices paired with a robust data management and monitoring platform that helps drive patient engagement.
Smart Meter is the foundation of the RPM Ecosystem
Smart Meter has propelled virtual care forward with our full suite of cellular-connected, FDA approved devices paired with a robust data management and monitoring platform that helps drive patient engagement.
Our Cellular-Connected Devices
US Patent Nos.: 10,311,208; 10,783,987; 10,783,988. UK Patent No. GB2542056. Canada Patent No. 2953253
iBloodPressure™
Now Available with an Extra-Large Cuff
iGlucose®
iScale™
iPulseOx™
Our Cellular-Connected Devices
US Patent Nos.: 10,311,208; 10,783,987; 10,783,988. UK Patent No. GB2542056. Canada Patent No. 2953253
Current Partners
Join the hundreds of market-leading RPM companies utilizing Smart Meter’s powerful cellular SmartRPM technology.
Smart Meter by the Numbers
300+
Distribution Partners
80,000+
Patients Monitored Daily
10m+
Patient Readings
99.9%
Device reliability1
Smart Meter by the Numbers
300+
Distribution Partners
80,000+
Patients Monitored Daily
10m+
Patient Readings
99.9%
Device reliability1
Cellular Remote Patient Monitoring:
Immediate. Reliable. Actionable.
Smart Meter eliminates the complex, extra steps—and delay—of sharing health metrics. All patients do is test by pressing a single button on iGlucose and iBloodPressure or simply stepping on the iScale. Clinicians benefit from access to cellular transmitted, real-time, reliable and secure patient data between visits, which can lead to better patient out comes.
Testimonials
"iGlucose’s ability to send BG data to our platform without syncing, pairing, home hubs or cables, is the perfect solution."– Joshua Claman, Former Chief Executive Officer, Rimidi
"Data flowing into the population management portal has quickly become an essential tool in managing diabetes for our patients. …iGlucose system drives better outcomes for our patients."– Joel Okner, MD, Cardiologist
"The iGlucose system with real-time data adds tremendous value to our diabetes education program ... The ability to have real-time data in making therapy decisions has been a huge plus."– Vivian N. Ayuk, PharmD, CDE, Chief Executive Officer, Flexcare Health Solutions
"Because of the remote patient monitoring available with your iGlucose meters, we will discuss the utility of remote patient monitoring for many patients. I can’t thank your company enough for enabling our future physicians an opportunity to gain an understanding of what they might ask of their future patients. "– Kathryn R Goldman, MD, Assistant Professor of Medicine, University of Connecticut School of Medicine
News + Events
Smart Meter partners with AT&T IoT for better health outcomes
Read More | January 3, 2022
Press Release | December 21, 2021
Smart Meter Announces Partnership With A&D Medical
Smart Meter partners with AT&T IoT for better health outcomes
Read More | January 3, 2022
*Better Data. Better Care. Better Outcomes. Reference: Self-Monitoring of Blood Glucose: A Prerequisite for Diabetes Management in Outcome Trials Oliver Schnell, MD1, Markolf Hanefeld, MD2, and Louis Monnier, MD3
1 – 99.9% of active patients have zero product issues based on over 2 million clinical readings March – August 2021.